Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
about
Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease.Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD.Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon-alfa and ribavirin.
P2860
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@ast
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@en
type
label
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@ast
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@en
prefLabel
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@ast
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@en
P2093
P2860
P1433
P1476
Microarray technology in the study of obesity and non-alcoholic fatty liver disease.
@en
P2093
Ancha Baranova
Rochelle Collantes
Shobha Gowder
Vikas Chandhoke
Zobair M Younossi
P2860
P304
P356
10.1111/J.1478-3231.2005.01183.X
P577
2005-12-01T00:00:00Z